OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Ocean Biomedical, Inc.
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026
- Market cap
- $45.51K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 232M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Waqas Khatri | 3,873,632 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Polar Asset Management Partners Inc. | 2,688,193 | 7.70% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of OCEA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | 600 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 5 | 0M | 1M |
| Q2 2025 | 6 | 1M | 0.3% | 2 / 2 | 1 / 19 | 1M | 4M |
| Q1 2025 | 23 | 5M | 2.0% | 8 / 5 | 4 / 6 | 1M | 0M |
| Q4 2024 | 21 | 4M | 1.6% | 4 / 6 | 5 / 3 | 0M | 0M |
| Q3 2024 | 20 | 4M | 1.5% | 4 / 1 | 11 / 18 | 0M | 0M |
| Q2 2024 | 35 | 4M | 1.7% | 7 / 10 | 14 / 15 | 1M | 1M |
| Q1 2024 | 43 | 5M | 2.0% | 13 / 8 | 15 / 5 | 1M | 1M |
| Q4 2023 | 35 | 5M | 2.2% | 5 / 14 | 8 / 6 | 0M | 1M |
| Q3 2023 | 38 | 6M | 2.7% | 5 / 13 | 10 / 2 | 0M | 1M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Poseidon Bio, LLC 10% owner | Oct 2, 2023 | Other | −500,000 | – | – | 22,342,756 |
| Surendra K. Ajjarapu Director | Mar 22, 2023 | Other | −1,050,000 | – | – | 315,000 |
| Surendra K. Ajjarapu Director, 10% owner | Feb 28, 2023 | Other | +21,252 | – | – | 21,252 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 28, 2023 | Other | −2,625,000 | – | – | 1,365,000 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 28, 2023 | Other | +469,300 | – | – | 469,300 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 28, 2023 | Other | +258,200 | – | – | 258,200 |
| Michael L. Peterson Director | Feb 28, 2023 | Other | +80,000 | – | – | 80,000 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 14, 2023 | Conversion | +2,625,000 | – | – | 3,990,000 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 14, 2023 | Other | −3,990,000 | – | – | 0 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 14, 2023 | Other | +3,990,000 | – | – | 3,990,000 |
| Aesther Healthcare Sponsor, LLC 10% owner | Feb 14, 2023 | Award | +1,365,000 | – | – | 1,365,000 |
| Poseidon Bio, LLC 10% owner | Feb 14, 2023 | Other | +22,842,756 | – | – | 22,842,756 |
| Poseidon Bio, LLC 10% owner | Feb 14, 2023 | Award | +22,842,756 | $10.00 | $228.43M | 22,842,756 |
| Poseidon Bio, LLC 10% owner | Feb 14, 2023 | Other | −456,852 | – | – | 0 |
| Poseidon Bio, LLC 10% owner | Feb 14, 2023 | Other | +456,852 | – | – | 456,852 |
| Poseidon Bio, LLC 10% owner | Feb 14, 2023 | Other | −22,842,756 | – | – | 0 |
| Poseidon Bio, LLC 10% owner | Feb 14, 2023 | Award | +456,852 | $10.00 | $4.57M | 456,852 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.